Navigation Links
Oral contraceptives safe for women with Lupus erythematosus

Lupus erythematosus (lupus) is a disease in which the body's immune system mistakenly attacks and damages healthy tissues of the skin, joints and internal organs.// A study has found that women who suffer from this disease can take oral contraceptives safely without any complications like increased risk of flares, or periods of increased disease activity, that characterize the disease.

The study was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH).

The entire study can be described as stated by the researchers as a 15-center study of 183 women with inactive or stable lupus. The women who were taking oral contraceptives (triphasic 35 μg.ethinylestradiol/0.5-1 mg norethindrone for twelve 28-day cycles) had no statistically significant difference in the occurrence of flares than those taking a placebo. Severe flares occurred in about 7 percent of the women, regardless of whether they received oral contraceptives or placebo. A severe flare was defined by several criteria, including the presence of new or worsening central nervous system involvement; inflammation of the blood vessels, kidneys and/or muscles; and/or blood problems, including low platelet count and destruction of the red blood cells.

As put by the authors of the study, "There are settings in which estrogens might provide benefit. Among women with lupus there is a high elective abortion rate – approaching 23 percent of pregnancies – which may reflect a failure of the birth control method used or the absence of an adequate birth control program."

In the words of NIAMS Director Stephen I. Katz, M.D., Ph.D, "Estrogen, as used in this study, appears to be safe in the majority of women with stable disease.This research brings us another step forward in improving quality of life for people with rheumatic disease."

'"/>




Page: 1

Related medicine news :

1. Hormone contraceptives lead to bone problems
2. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
3. Lower doses of oral contraceptives helpful in treating acne
4. Dermaseptins: Potent vaginal contraceptives
5. Do oral contraceptives offer protective cover against endometrial cancer?
6. Transdermal HRT not cardioprotective in postmenopausal women with CAD
7. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
8. Starvation in pregnant women can cause heart disease to their children
9. Brisk Walking lowers memory loss in women
10. Young womens woes
11. Young womens woes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... September 19, 2017 , ... PAPA Healthcare, Inc. announced today, ... “PAPA Healthcare helps fill gaps, provide essential insights, and improve productivity.” The ... by leveraging PAPA Healthcare’s post-acute productivity and analytics solutions. , St. Vincent’s Home ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... Texas as a part of its national Swirl: A Wine Tasting Event series ...
(Date:9/19/2017)... ... September 19, 2017 , ... The American ... Americans to watch for the discomforts and hidden dangers of foot fungus, particularly ... everyone is at risk for developing fungal infections on the feet or toenails, ...
(Date:9/19/2017)... ... September 19, 2017 , ... The Workgroup for Electronic Data Interchange (WEDI) ... efficiencies in healthcare information exchange and a trusted advisor to the U.S. Department of ... paper, entitled Barriers to Adoption of the ERA and EFT Transactions . ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... Driving Dynamics ... Safety Training Company by Training Industry Inc. as part of its mission to continually ... , Selection to the first annual 2017 Top 20 Health and Safety Training Companies ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017  Eli Lilly and Company (NYSE: ... operations to more efficiently focus resources on developing ... Global workforce reductions, including those from a U.S. ... approximately 3,500 positions. With the ... of approximately $500 million that will begin to ...
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:9/6/2017)... PDI , a leader in infection prevention products and ... focused on the role of chlorhexidine gluconate (CHG) in ... Annual Scientific Meeting of the Association for Vascular Access. ... Phoenix Convention Center in ... feature PDI,s Prevantics® Device Swab as the ...
Breaking Medicine Technology: